Hepatic bile acid accretion correlates with cholestatic liver injury and therapeutic response in Cyp2c70 knockout mice with a humanized bile acid composition
American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.12.2024 · 327 (6) · G789-G809
DOI: 10.1152/ajpgi.00129.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.12.2024. Verfasst von Caroline Klindt und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, United States. Hauptthemen laut MEDLINE: Bile Acids and Salts, Mice, Knockout, Liver. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIDDK NIH HHS, Meredith Brown Fund at Emory University.
Abstract (Originalsprache)
Bile acids are implicated as a common contributor to the pathogenesis and progression of cholestatic liver disease. Using a mouse model with a humanized bile acid composition, we demonstrated that mono and combination therapy using an IBAT inhibitor and FXR nonsteroidal agonist were effective at reducing hepatic bile acid accretion and reversing liver injury, without reducing hepatic bile acid hydrophobicity. The findings support the concept of a therapeutically tractable threshold for bile acid-induced liver injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, United States.
- Department of Gastroenterology, Hepatology and Infectious Diseases, Heinrich-Heine University, Duesseldorf, Germany.
- Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
- Rectify Pharma, Cambridge, Massachusetts, United States.
- Department of General Pediatrics, Neonatology and Pediatric Cardiology, Medical Faculty and University Hospital Duesseldorf, Heinrich-Heine University Duesseldorf, Duesseldorf, Germany.
- Stravitz-Sanyal Liver Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University, Richmond, Virginia, United States.
ORCID-Profile: Saul J Karpen, Paul A Dawson
Förderung
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NIDDK NIH HHS
- Meredith Brown Fund at Emory University
- Mason Trust Fund at Emory University
- Deutsche Forschungsgemeinschaft (DFG)
Zitieren
APA
Klindt, C., Truong, J. K., Bennett, A. L., Pachura, K. J., Herebian, D., Mayatepek, E., Luedde, T., Ebert, M., Karpen, S. J., & Dawson, P. A. (2024). Hepatic bile acid accretion correlates with cholestatic liver injury and therapeutic response in Cyp2c70 knockout mice with a humanized bile acid composition. American Journal of Physiology-Gastrointestinal and Liver Physiology, 327(6), G789-G809. https://doi.org/10.1152/ajpgi.00129.2024
Vancouver
Klindt C, Truong JK, Bennett AL, Pachura KJ, Herebian D, Mayatepek E, et al. Hepatic bile acid accretion correlates with cholestatic liver injury and therapeutic response in Cyp2c70 knockout mice with a humanized bile acid composition. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2024;327(6):G789-G809. doi:10.1152/ajpgi.00129.2024
BibTeX
@article{Klindt2024,
author = {Klindt, Caroline and Truong, Jennifer K and Bennett, Ashley L and Pachura, Kimberly J and Herebian, Diran and Mayatepek, Ertan and Luedde, Tom and Ebert, Matthias and Karpen, Saul J and Dawson, Paul A},
title = {Hepatic bile acid accretion correlates with cholestatic liver injury and therapeutic response in Cyp2c70 knockout mice with a humanized bile acid composition},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2024},
volume = {327},
number = {6},
pages = {G789--G809},
doi = {10.1152/ajpgi.00129.2024}
}
EUVIMED